Disease / condition

Hepatitis B clinical trials

Free access to 301 studies·10+ countries·Updated daily31 recruiting
301
Total trials
10+
Countries
10+
Sponsors
31
Recruiting
By phase
N/A96
Phase 357
Phase 453
Phase 239
Phase 138
By status
Completed185
Unknown34
Recruiting31
Terminated21
Not yet recruit...19
Top countries
China39
United States of America32
South Korea16
Belgium12
Thailand12
Top sponsors
GlaxoSmithKline66
Gilead Sciences10
Bukwang Pharmaceut...9
Merck Sharp & Dohm...6
National Institute...6
Recent trials
Latest clinical trials for Hepatitis B
2016-003981-15
Assessment of Hepatitis B Vaccine Manufactured by a Modified Process in Healthy Neonates (babies 1 to 10 days old)
Merck & Co., Inc.
NCT06058390·Phase 1Not yet recr...
A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants
GlaxoSmithKlineUnited States of America
NCT05957380·Phase 4Recruiting
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
Dong-A ST Co., Ltd.South Korea
NCT05768061Not yet recr...
HBV Reactivation in Anti CD20 Treatment
HaEmek Medical Center, IsraelIsrael
ANZCTR12623000074695·Phase 1Not yet recr...
A Study of AB-161 Following Oral Administration in Healthy Subjects
Arbutus Biopharma CorporationNew Zealand
NCT05686759·Phase 3Recruiting
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
GC Biopharma CorpSouth Korea
NCT05561673·Phase 1/2Recruiting
A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years
GlaxoSmithKlineUnited Kingdom
NCT05446532Recruiting
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes
Corporacion Parc TauliSpain
NCT05442372Recruiting
Prevalence of HBV in Pregnancy
Sohag UniversityEgypt
NCT05330455·Phase 1/2Recruiting
Study of GSK3965193 in Healthy Participants and Alone and in Combination With Bepirovirsen in Participants Living With Chronic Hepatitis B Infection
GlaxoSmithKlineUnited Kingdom
NCT05275465·Phase 1Recruiting
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
Huahui HealthAustralia
NCT05272735·Phase 4Not yet recr...
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
Rockefeller UniversityUnited States of America
ChiCTR2200055418·Phase 1Recruiting
Untitled Trial
Dongzhimen Hospital, Beijing U...China
ChiCTR2100053602·Phase 4Not yet recr...
Untitled Trial
Ruijin Hospital, Shanghai Jiao...China
NCT05144776Recruiting
Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool
Kirby InstituteAustralia
NCT04954859·Phase 2Not yet recr...
Long-term Follow-up Study to Evaluate Durability of Sustained Virologic Response (SVR) in Previous GSK3228836 Study Participants (B-Sure)
GlaxoSmithKline
NCT04971928·Phase 1Recruiting
Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment
GlaxoSmithKlineUnited States of America
NCT04914611Recruiting
Real World Assessment of People Living With Chronic Hepatitis B in Australia
Kirby InstituteAustralia
NCT04906109·Phase 1Not yet recr...
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects
Dong-A ST Co., Ltd.South Korea
NCT04868981·Phase 1Completed
Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets
Fujian Cosunter Pharmaceutical...China
About this record

Access comprehensive clinical trial information for Hepatitis B through Pure Global AI's free database. This collection includes 301 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 31 trials are actively recruiting participants.

Research for Hepatitis B is being conducted in China, United States of America, South Korea and 7+ other countries. Leading sponsors include GlaxoSmithKline and Gilead Sciences. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 301 clinical trials studying Hepatitis B, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include GlaxoSmithKline, Gilead Sciences, Bukwang Pharmaceutical, among others.